Olanzapine
Product Images NDC 67296-1668

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 67296-1668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

Olanzapine Tablets USP 2.5 mg carton label. The package contains 30 tablets, labeled with NDC 69543-380-30. It includes storage instructions, dosage information, manufacturer details (Olai Pharmaceutical Co., Ltd.), and distributor info (Virtus Pharmaceuticals, Lansdowne, PA). The label states Rx only and cautions to keep out of reach of children.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

Olanzapine Tablets USP 2.5 mg label showing a box containing 30 tablets. The label includes directions to dispense the accompanying medication guide, storage instructions at controlled room temperature, lot number, expiration, and other identifiers. Manufactured by Jiu Pharmaceuticals Co., Ltd. and distributed by Virtus Pharmaceuticals, LLC.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

Olanzapine Tablets, USP label for a package of 30 tablets. It includes dosage strength of 5 mg per tablet and usage instructions such as keeping the container tightly closed, storage conditions, and pharmacist dispensing requirements. Manufactured by Qilu Pharmaceutical Co., Ltd. and distributed by Virtus Pharmaceuticals, LLC.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 5 mg bottle label from RedPharm Drug. The label indicates a count of 30 tablets with the product NDC 69543-381-30, includes dosage instructions, storage conditions, a barcode, and manufacturing details by Qilu Pharmaceutical Co., Ltd., with Virtus Pharmaceuticals as the distributor.*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 7.5 mg label showing product name, strength, dosage form, pack size of 30 tablets, and labeler as Virtus Pharmaceuticals. The label includes pharmacist instructions, storage conditions, manufacturer and distributor information, a barcode, and a note about accompanying medication guide and prescription status (Rx only).*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 7.5 mg label showing a carton for 30 tablets by Virtus Pharmaceuticals. The label includes the NDC number 69543-382-30, dosage strength, dispensing instructions, storage conditions, manufacturer information, a 2D code, and space for lot, expiration, serial, and GTIN numbers.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

Packaging label for Olanzapine Tablets, USP 10 mg by RedPharm Drug, showing the NDC 69543-383-30. The label indicates a bottle containing 30 tablets with instructions for the pharmacist to dispense the medication guide. Storage instructions, manufacturer, and distributor information are also included.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

Olanzapine Tablets USP 10 mg label showing a 30-tablet package. The label includes directions to keep the bottle tightly closed and out of reach of children, pharmacist instructions to dispense the medication guide, and storage conditions at controlled room temperature 20 to 25°C (68 to 77°F). The label displays a barcode, 2D code, manufacturer and distributor information, and revision date 08/2018. The labeler is Virtus Pharmaceuticals.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 15 mg label showing product name, strength, and quantity of 30 tablets. The label instructions include keeping the bottle tightly closed and out of reach of children, with storage at controlled room temperature. The label indicates the manufacturer as Qilu Pharmaceutical Co., Ltd., China, distributed by Virtus Pharmaceuticals, LLC. The NDC code visible is 69543-384-30.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

Olanzapine Tablets USP 15 mg package label displaying the NDC number 69543-384-30. The label indicates the product contains 30 tablets and is labeled by Virtus Pharmaceuticals. Directions include keeping the medication out of children's reach and dispensing a medication guide to patients. Storage instructions and manufacturer details are partly visible on the right side.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

Olanzapine Tablets, USP 20 mg bottle label by Virtus Pharmaceuticals. The label includes dosage strength, quantity (30 tablets), and usage instructions such as keeping tightly closed and storing at controlled room temperature. It also provides manufacturer and distributor details, Rx only designation, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

Packaging label for Olanzapine Tablets, USP 20 mg, containing 30 tablets. The label includes dosing and storage instructions, emphasizing use under a pharmacist's guidance and keeping the drug out of reach of children. It is manufactured by Qilu Pharmaceutical Co., Ltd and distributed by Virtus Pharmaceuticals, LLC. The label also features a barcode and placeholders for lot, expiration, serial numbers, and GTIN.*

FDA Label Image

Image Description (Olanzapine Str)

Chemical structure of Olanzapine, depicting its molecular arrangement including nitrogen, sulfur, and methyl groups within the fused ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.